Search Results

• • 10,366 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Prognostic significance of Subjective Global Assessment (SGA) in advanced colorectal cancer

  Authors:D Gupta, C A Lammersfeld, P G Vashi, J Burrows, C G Lis, and J F GrutschFrom:European Journal of Clinical Nutrition (Vol. 59, Issue 1) Peer-Reviewed

  Jan. 20053,834 words Report Objective:: To evaluate the prognostic significance of Subjective Global Assessment (SGA) in advanced colorectal cancer and create statistically distinct prognostic groups of colorectal cancer patients based on clinical...

• Fentanyl pectin nasal spray: a novel intranasal delivery method for the treatment of breakthrough cancer pain

  Authors:Marilyn N Bulloch and Amber M HutchisonFrom:Expert Review of Clinical Pharmacology (Vol. 6, Issue 1) Peer-Reviewed

  Jan. 201313,156 words Clinical report 1550LAuthor(s): Marilyn N Bulloch [*] 1 2 , Amber M Hutchison 2 Keywords : breakthrough cancer pain; fentanyl; intranasal; pectin For many patients with cancer, moderate-to-severe pain becomes an ever present and...

• Little Money of Children's Cancer Charity Goes to Main Programs

  Author:Caroline PrestonFrom:The Chronicle of Philanthropy (Vol. 25, Issue 07)

  Feb. 24, 20133,013 words Article 1480LByline: Caroline Preston Since recovering from lung cancer in 1985, Greg Anderson has written more than a dozen books on holistic approaches to fighting cancer and built an international network of nonprofits to help...

• Beyond genetics in personalized cancer treatment: assessing dynamics and heterogeneity of tumor responses

  Authors:Darren R Tyson and Vito QuarantaFrom:Personalized Medicine (Vol. 10, Issue 3) Peer-Reviewed

  May 20133,074 words Article 1780LAuthor(s): Darren R Tyson [*] 1 , Vito Quaranta 2 KEYWORDS : cancer therapeutics; dynamic treatment response; single-cell analysis; tumor heterogeneity Cancer has been considered a genetic disease for over a...

• Can one size fit all? Translating models of cancer survivorship care for older patients

  Authors:Roxanne E Jensen, Leigh Anne Faul, Waddah B Al-Refaie, and Arnold L PotoskyFrom:Aging Health (Vol. 9, Issue 4) Peer-Reviewed

  Aug. 20132,628 words Editorial 1520LAuthor(s): Roxanne E Jensen [*] 1 , Leigh Anne Faul 2 , Waddah B Al-Refaie 3 , Arnold L Potosky 4 Keywords * elderly; health services; oncology; quality of healthcare There are currently 13.7 million cancer...

• Oral metronomic scheduling of anticancer therapy-based treatment compared to existing standard of care in locally advanced oral squamous cell cancers: A matched-pair analysis

  Authors:P. Pai, A. Vaidya, K. Prabhash, and S. BanavaliFrom:Indian Journal of Cancer (Vol. 50, Issue 2) Peer-Reviewed

  April-June 20134,480 words Report 1660LByline: P. Pai, A. Vaidya, K. Prabhash, S. Banavali Context: Head and neck cancers in developing countries present with advanced disease, compounded by poor access to tertiary care centers. Aim: We evaluated oral...

• Treatment of Wilms tumor in low-income countries: challenges and potential solutions

  Authors:Trijn Israels, Mhamed Harif, and Kathy Pritchard-JonesFrom:Future Oncology (Vol. 9, Issue 8) Peer-Reviewed

  Aug. 20131,626 words Report 1370LAuthor(s): Trijn Israels 1 , Mhamed Harif 2 , Kathy Pritchard-Jones [*] 3 Keywords * Africa; low-income countries; nephroblastoma; Wilms tumor Wilms tumor is a relatively common and curable childhood renal...

• Cancer treatment regimens

  From:MPR Hematology and Oncology Edition (Vol. 6, Issue 3)

  Fall 2013154 words Article 1160LMPR is pleased to include up-to-date cancer treatment regimens with every issue of our Hematology & Oncology edition. Find these treatment regimens and additional updates at ChemotherapyAdvisor.com. Just click on...

• Clinico-pathological impact of cytogenetic subgroups in B-cell chronic lymphocytic leukemia: Experience from India

  Authors:PS Amare, V. Gadage, H. Jain, S. Nikalje, S. Manju, N. Mittal, et al.From:Indian Journal of Cancer (Vol. 50, Issue 3) Peer-Reviewed

  July-September 20134,038 words Report 1680LByline: PS. Amare, V. Gadage, H. Jain, S. Nikalje, S. Manju, N. Mittal, S. Gujral, R. Nair Background: The present study of 238 B-cell Chronic Lymphocytic Leukemia (B-CLL) patients were undertaken to seek the...

• Proteomics and metabolomics in cancer drug development

  Authors:Angelo D'Alessandro and Lello ZollaFrom:Expert Review of Proteomics (Vol. 10, Issue 5) Peer-Reviewed

  Oct. 201313,367 words Report 1670LAuthor(s): Angelo D'Alessandro 1 , Lello Zolla [*] 2 Keywords : cancer; drug development; mass spectrometry; metabolism; proteomics Metabolomics, the new/old hallmark of cancer Human tumor pathogenesis is...

• Comparative study of polymorphism frequencies of the CYP2D6, CYP3A5, CYP2C8 and IL-10 genes in Mexican and Spanish women with breast cancer

  Authors:Gregorio Antonio Alcazar-Gonzalez, Ana Laura Calderon-Garciduenas, Maria Lourdes Garza-Rodriguez, Gabriela Rubio-Hernandez, Sergio Escorza-Trevino, Estibaliz Olano-Martin, et al.From:Pharmacogenomics (Vol. 14, Issue 13) Peer-Reviewed

  Oct. 20136,223 words Report 1360LAuthor(s): Gregorio Antonio Alcazar-González 1 , Ana Laura Calderón-Garcidueñas 2 , María Lourdes Garza-Rodríguez 3 , Gabriela Rubio-Hernández 4 , Sergio Escorza-Treviño 5 , Estibaliz Olano-Martin 6 , Ricardo Martín...

• Conclusion

  Author:Jalid SehouliFrom:Future Oncology (Vol. 9, Issue 12s) Peer-Reviewed

  Dec. 2013496 words Article 1450LAuthor(s): Jalid Sehouli 1 Keywords * fully platinum-sensitive; mechanism of action; ovarian cancer; partially platinum-sensitive; pegylated liposomal doxorubicin; trabectedin As researchers and clinicians...

• Application of genotype-guided cancer therapy in solid tumors

  Author:Jai N PatelFrom:Pharmacogenomics (Vol. 15, Issue 1) Peer-Reviewed

  Jan. 201410,089 words Report 1540LAuthor(s): Jai N Patel 1 KEYWORDS : biomarkers; cancer; genetics; genotype; pharmacogenetics; therapy; tumors The clinical problem The genome of cancer cells differs slightly, albeit in a significant...

• Antiproliferative effects of n-butyl-[beta]-D-fructofuranoside from Kangaisan on Bel-7402 cells

  Authors:Ping Lu, Miao Li, Yiceng Lou, Fengping Su, Hongling Li, Xiang Zhao, et al.From:Indian Journal of Pharmacology (Vol. 46, Issue 1) Peer-Reviewed

  January-February 20143,294 words Report 1640LByline: Ping. Lu, Miao. Li, Yiceng. Lou, Fengping. Su, Hongling. Li, Xiang. Zhao, Yali. Cheng Aims: Kangaisan is a powdered compound prescription of Traditional Chinese Medicine which has been used in cancers for...

• Ovarian cancer treatment regimens

  From:MPR Hematology and Oncology Edition (Vol. 7, Issue 1)

  Spring 2014 Brief article OVARIAN CANCER TREATMENT REGIMENS Principle of therapy: All regimens involving primary chemotherapy/ primary adjuvant therapy include intravenous (IV) and intraperitoneal (IP) options, and may be used for epithelial...

• Radioimmunotherapy with [alpha]-particle-emitting radionuclides

  Author:Christof SeidlFrom:Immunotherapy (Vol. 6, Issue 4) Peer-Reviewed

  Apr. 201420,613 words Report 1910LAuthor(s): Christof Seidl aff1 Keywords: * [alpha]-emitter; antibody; radioimmunotherapy; radionuclide; targeted therapy Background Radionuclides that emit [alpha]- or [beta]-particles exhibit a high...

• Tumor heterogeneity and implications for clinical practice

  Author:Edward ChuFrom:Oncology (Vol. 28, Issue 9) Peer-Reviewed

  Sept. 20141,030 words Article 1590LSince the late 1890s, when morphologic tumor heterogeneity was first described by pathologists, tumor heterogeneity has been recognized as an important and relevant clinical problem. From the discovery of tumor...

• Cancer- and treatment-related cognitive changes: what can we do now? What lies ahead?

  Authors:Catherine M. Bender and John D. MerrimanFrom:Oncology (Vol. 28, Issue 9) Peer-Reviewed

  Sept. 20141,884 words Article 2070LThe common term "chemobrain" belies the complex nature of the problem of changes in cognitive function experienced by patients with cancer. [1] Multiple factors contribute to these cognitive changes. Moreover, some...

• LR040--Annona Muricata, the rising star phenomenon for cancer cure: an evidence-based review

  Author:Dinisa Diah WinariFrom:Journal of Asian Medical Student Association (Vol. 2, Issue S2) Peer-Reviewed

  June 2013145 words Author abstract, Bri... Natural products have been the targets for cancer therapy for several years but there is still a dearth of information on potent compounds that may protect normal cells and selectively destroy cancerous cells. This...

• The KDM5 family of histone demethylases as targets in oncology drug discovery

  Authors:Peter Birk Rasmussen and Peter StallerFrom:Epigenomics (Vol. 6, Issue 3) Peer-Reviewed

  June 20147,101 words Report 1890LAuthor(s): Peter Birk Rasmussen aff1 aff2 , Peter Staller [*] aff1 Keywords: cancer; enzymatic inhibitors; epigenetics; gene transcription; H3K4 methylation; histone demethylase; jumonji; oncogenes The KDM5...